Question explored with the scientific record
Gender affirming care, what is the evidence of benefit to minors?
The honest answer: the retrieved evidence contains almost nothing on minors, and nothing at all on the outcome that matters most, whether gender-affirming care improves their mental health or survival.
The question asks about benefit to minors. The records that actually match are thin. One scoping review of 20 brain-imaging studies in gender-diverse adolescents found functional connectivity differences and noted that long-term effects of hormone therapy are underrepresented, with a call for multicenter work [5]. That is a description of brain scans, not a measure of benefit. A study of transgender veterans found lower suicidal ideation and depression in those who had both hormones and surgery [6], but those are adults, and a cross-sectional look at who chose treatment cannot tell you the treatment caused the improvement. The rest of the retrieval is about adults: surgical orgasm rates [1], testicular tissue changes [2], and cardiovascular risk on hormones [3][4]. None of it answers the question for a child.
What the evidence does show is real risk on the hormone side. In a Dutch registry cohort, transgender women on hormones had about 1.8 times the expected rate of blood clots, and transgender men had about 4.25 times the expected heart attacks compared with women [4]. Those are adults, and the numbers are small in absolute terms, but they are the kind of hard outcome that a pediatric decision should be weighed against.
| Group (adults) | Outcome | Rate vs comparison |
|---|---|---|
| Trans women on estrogen | Blood clots | ~1.8x expected [4] |
| Trans women on estrogen | Heart attack vs women | ~1.6x, falls to ~1.3x after adjustment [4] |
| Trans men on testosterone | Heart attack vs women | ~4.25x expected [4] |
The retrieval did not surface a single randomized trial of puberty blockers or hormones in minors measuring depression, suicide, or bone density. That absence is a fact about this search, not proof none exist. But you asked what the evidence of benefit is, and on this record the answer is that the benefit to minors is asserted far more than it is demonstrated.
My call: the evidence here does not establish clinical benefit of gender-affirming care for minors, and the safety data in children is largely missing. Confidence: low, because the retrieval barely touches the pediatric question.
Sources used 6
-
Post-surgical outcomes in transgender women: a prospective analysis of sexual function and health-related quality of life
Penile inversion vaginoplasty in transgender women yields favorable long-term orgasm outcomes (74% at 6 months, 79.4% at 12 months) with stable physical quality of life, although mental health-related QoL remains below population norms, and younger age (<40) predicts better phys…
DOI: 10.1007/s00345-025-05887-9 -
Partial rejuvenation of the spermatogonial stem cell niche after gender-affirming hormone therapy in trans women
This study investigates the effects of gender-affirming hormone therapy on the spermatogonial stem cell niche in trans women, revealing partial rejuvenation and significant histological changes in testicular tissue.
DOI: 10.7554/eLife.94825 -
Cardiovascular disease in transgendered people: A review of the literature and discussion of risk
This narrative review synthesises evidence that gender-affirming hormone therapy in transgender women is neutral or protective for myocardial infarction but increases venous thromboembolism and possibly stroke, while in transgender men adverse lipid changes do not clearly transl…
DOI: 10.1177/2048004019880745 -
Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study
A large Dutch retrospective cohort study using national registry data to assess cardiovascular event risk in transgender people on gender-affirming hormone therapy (GAHT), finding reduced myocardial infarction risk in transgender women, increased myocardial infarction risk in tr…
DOI: 10.1093/eurheartj/ehaf837 -
Neuroimaging insights into transgender and gender nonconfirming youth: a scoping review
A scoping review of 20 neuroimaging studies (2013–2024) in transgender and gender-diverse adolescents, detailing imaging modalities, study designs (cross-sectional and longitudinal), and associations between brain structure/function and gender identity, including effects of gend…
DOI: 10.1186/s13034-025-00987-1 -
Hormone therapy, gender affirmation surgery, and their association with recent suicidal ideation and depression symptoms in transgender veterans
This study investigates the relationship between hormone therapy, gender affirmation surgery, and their association with suicidal ideation and depression symptoms in a national sample of transgender veterans, finding that those who underwent both hormone therapy and surgery repo…
DOI: 10.1017/S0033291717003853